Dementia

Dementia

Are biomarkers for Alzheimer’s disease ready for clinical practice? 2:25
Are biomarkers for Alzheimer’s disease ready for clinical practice?
Giancarlo Logroscino
Debating controversies in ALS 2:54
Debating controversies in ALS
Ettore Beghi
COVID-19: managing neurodegenerative diseases in southern Italy 6:13
COVID-19: managing neurodegenerative diseases in southern Italy
Giancarlo Logroscino
Defining Alzheimer’s disease: clinical or biological 2:22
Defining Alzheimer’s disease: clinical or biological
Bart De Strooper
Cross neurodegenerative disease genetic analysis: similarities and differences 2:20
Cross neurodegenerative disease genetic analysis: similarities and differences
John Hardy
The reconstructed cohort design: tracking rare neurodegenerative diseases 4:40
The reconstructed cohort design: tracking rare neurodegenerative diseases
Giancarlo Logroscino
Hopeful developments for Alzheimer’s Disease 1:21
Hopeful developments for Alzheimer’s Disease
Bart De Strooper
The benefits of GWAS in understanding Alzheimer’s disease 2:00
The benefits of GWAS in understanding Alzheimer’s disease
John Hardy
Therapeutic development in Alzheimer’s disease and the lack of funding 2:02
Therapeutic development in Alzheimer’s disease and the lack of funding
Bart De Strooper
The potential of biomarkers in dementia 3:08
The potential of biomarkers in dementia
Giancarlo Logroscino
Identifying new therapeutic targets for neurodegenerative diseases 1:34
Identifying new therapeutic targets for neurodegenerative diseases
Bart De Strooper
Cycad toxins driving the ALS-Parkinsonism-Dementia complex 2:40
Cycad toxins driving the ALS-Parkinsonism-Dementia complex
Peter Spencer
Cognitive impairment in Parkinson’s disease & white matter hyperintensities 2:40
Cognitive impairment in Parkinson’s disease & white matter hyperintensities
Kathleen Poston
The power of biomarkers: movement disorders 7:35
The power of biomarkers: movement disorders
James Rowe
The under-representation of females in research: impact in drug development 1:53
The under-representation of females in research: impact in drug development
Christina Dalla
The importance of sex differences in neuroscience 1:20
The importance of sex differences in neuroscience
Christina Dalla
The content of VJNeurology is intended for healthcare professionals